Syngene International's Stock Sees 3.1% Increase, Outperforms Sector and Sensex

Syngene International, a leading pharmaceutical and drug company, saw a 3.1% increase in its stock on November 6, 2024. This gain was in line with the overall performance of the sector, as the company outperformed the sector by 2.04%. The stock also reached an intraday high of Rs 890, showing a 2.94% increase.

Syngene International has been consistently performing well, as it is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the company's stock.

In comparison to the Sensex, Syngene International's performance has been even better. On a 1-day basis, the company's stock saw a 3.10% increase, while the Sensex only saw a 0.61% increase. Similarly, on a 1-month basis, Syngene International's stock saw a 2.54% increase, while the Sensex saw a -2.11% decrease.

Overall, Syngene International has been showing strong performance in the pharmaceutical and drug industry, with its stock consistently outperforming the sector and the Sensex. Investors may want to consider holding onto their shares, as suggested by MarketsMOJO's 'Hold' rating for the stock.